ANN ARBOR, Mich. and PHOENIX, July 15, 2015 /PRNewswire-USNewswire/ -- Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing cancer testing for patients with cancer, today announced that it has entered into a contractual agreement with Stratose for coverage of PCDx.
PCDx is a Next-Generation Sequencing (NGS) based diagnostic test that is designed to provide physicians and patients with a more targeted, personalized approach to cancer treatment by identifying the underlying genomic and proteomic alterations of a patients tumor's DNA, RNA & Protein.
Dr. Robert Penny, MD, PhD, CEO of Paradigm, noted, "Through this contract, millions of Stratose client members and their treating clinicians will have access to this important oncology service and make possible more informed and individually tailored treatment strategies."
Stratose, based in Atlanta, GA, maintains one of the largest and growing directly managed PPO networks in the U.S., including more than 850,000 direct and affiliate medical, dental and workers' compensation provider contract. These members will now have access to Paradigm's PCDx.
Paradigm is a molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry by providing information about the genomic makeup of the patient's cancer and potential therapies based on the specific characterization of the patient's tumor that can impact the patient's course of treatment. Paradigm's Next-Generation Sequencing based diagnostic test PCDx provides oncologists and patients with more precise information about the specific cancer pathways in the patient and associations between the pathways and the specific drugs available that can affect the cancer to allow for more effective decision-making. The test is driven by supporting data and literature and provides more choices for patient care than currently available on the market. For more information visit http://www.paradigmdx.org @Paradigm_DX.
Stratose is a marketplace leader, providing comprehensive solutions for managing healthcare costs. Stratose utilizes proprietary technology and a suite of products and services to deliver industry leading discounts on medical, dental and workers' compensation billings by accessing direct provider contracts, PPO networks, provider negotiations, proprietary re-pricing including Medicare, to achieve industry leading savings for its national client base. Learn more at www.stratose.com.